Superior overall survival of patients with myeloma...

Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial

Dytfeld, Dominik, Griffith, Kent A., Friedman, Judah, Lebovic, Daniel, Harvey, Colleen, Kaminski, Mark S., Jakubowiak, Andrzej J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
52
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2011.567316
Date:
July, 2011
File:
PDF, 618 KB
english, 2011
Conversion to is in progress
Conversion to is failed